Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT

Abstract Aims The aim of the study was to explore the risk factors and evaluate the prognostic implication of pulmonary hospitalization on heart failure (HF) with preserved ejection fraction (HFpEF). Methods and results We performed a secondary analysis of the Treatment of Preserved Cardiac Function...

Full description

Bibliographic Details
Main Authors: Bin Dong, Xin He, Ruicong Xue, Yili Chen, Jingjing Zhao, Wengen Zhu, Weihao Liang, Zexuan Wu, Dexi Wu, Huiling Huang, Yuanyuan Zhou, Yugang Dong, Chen Liu
Format: Article
Language:English
Published: Wiley 2020-12-01
Series:ESC Heart Failure
Subjects:
Online Access:https://doi.org/10.1002/ehf2.12966
_version_ 1818977081705365504
author Bin Dong
Xin He
Ruicong Xue
Yili Chen
Jingjing Zhao
Wengen Zhu
Weihao Liang
Zexuan Wu
Dexi Wu
Huiling Huang
Yuanyuan Zhou
Yugang Dong
Chen Liu
author_facet Bin Dong
Xin He
Ruicong Xue
Yili Chen
Jingjing Zhao
Wengen Zhu
Weihao Liang
Zexuan Wu
Dexi Wu
Huiling Huang
Yuanyuan Zhou
Yugang Dong
Chen Liu
author_sort Bin Dong
collection DOAJ
description Abstract Aims The aim of the study was to explore the risk factors and evaluate the prognostic implication of pulmonary hospitalization on heart failure (HF) with preserved ejection fraction (HFpEF). Methods and results We performed a secondary analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial (TOPCAT). A total of 1714 patients with HFpEF were analysed in our study. In the multivariate Cox proportional hazards regression analysis, history of chronic obstructive pulmonary disease (COPD), smoking, bone fracture after the age of 45, and previous HF hospitalization were identified as independent risk factors for pulmonary hospitalization. To evaluate the prognostic significance of pulmonary hospitalization, patients were categorized into five groups according to the causes of their first hospitalization. The all‐cause and cardiovascular (CV) mortality risks in these five groups were compared using time‐varying Cox proportional hazards model. Compared with patients without hospitalization during follow‐up, those with pulmonary hospitalization were associated with a 204% increase [hazard ratio (HR) 3.04, 95% confidence interval (CI) 2.07–4.47, P < 0.001] and 164% increase (HR 2.64, 95% CI 1.60–4.36, P < 0.001) in risks of all‐cause and CV mortality, respectively, while the corresponding risk increases associated with HF hospitalization were 146% (HR 2.46, 95% CI 1.74–3.48, P < 0.001) for all‐cause mortality and 186% (HR 2.86, 95% CI 1.87–4.36, P < 0.001) for CV mortality. Conclusions Pulmonary hospitalization was associated with a significant increase in risks of all‐cause and CV mortality, which was comparable with that associated with HF hospitalization. The results suggested that pulmonary hospitalization could be another important clinical endpoint of HFpEF.
first_indexed 2024-12-20T16:22:04Z
format Article
id doaj.art-06806c4493dc42c78e3b4d87bd375c63
institution Directory Open Access Journal
issn 2055-5822
language English
last_indexed 2024-12-20T16:22:04Z
publishDate 2020-12-01
publisher Wiley
record_format Article
series ESC Heart Failure
spelling doaj.art-06806c4493dc42c78e3b4d87bd375c632022-12-21T19:33:35ZengWileyESC Heart Failure2055-58222020-12-01763801380910.1002/ehf2.12966Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCATBin Dong0Xin He1Ruicong Xue2Yili Chen3Jingjing Zhao4Wengen Zhu5Weihao Liang6Zexuan Wu7Dexi Wu8Huiling Huang9Yuanyuan Zhou10Yugang Dong11Chen Liu12Department of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaDepartment of Cardiology The First Affiliated Hospital of Sun Yat‐sen University Guangzhou 510080 ChinaAbstract Aims The aim of the study was to explore the risk factors and evaluate the prognostic implication of pulmonary hospitalization on heart failure (HF) with preserved ejection fraction (HFpEF). Methods and results We performed a secondary analysis of the Treatment of Preserved Cardiac Function Heart Failure with an Aldosterone Antagonist Trial (TOPCAT). A total of 1714 patients with HFpEF were analysed in our study. In the multivariate Cox proportional hazards regression analysis, history of chronic obstructive pulmonary disease (COPD), smoking, bone fracture after the age of 45, and previous HF hospitalization were identified as independent risk factors for pulmonary hospitalization. To evaluate the prognostic significance of pulmonary hospitalization, patients were categorized into five groups according to the causes of their first hospitalization. The all‐cause and cardiovascular (CV) mortality risks in these five groups were compared using time‐varying Cox proportional hazards model. Compared with patients without hospitalization during follow‐up, those with pulmonary hospitalization were associated with a 204% increase [hazard ratio (HR) 3.04, 95% confidence interval (CI) 2.07–4.47, P < 0.001] and 164% increase (HR 2.64, 95% CI 1.60–4.36, P < 0.001) in risks of all‐cause and CV mortality, respectively, while the corresponding risk increases associated with HF hospitalization were 146% (HR 2.46, 95% CI 1.74–3.48, P < 0.001) for all‐cause mortality and 186% (HR 2.86, 95% CI 1.87–4.36, P < 0.001) for CV mortality. Conclusions Pulmonary hospitalization was associated with a significant increase in risks of all‐cause and CV mortality, which was comparable with that associated with HF hospitalization. The results suggested that pulmonary hospitalization could be another important clinical endpoint of HFpEF.https://doi.org/10.1002/ehf2.12966Heart failure with preserved ejection fractionPulmonary hospitalizationRisk factorsPrognosis
spellingShingle Bin Dong
Xin He
Ruicong Xue
Yili Chen
Jingjing Zhao
Wengen Zhu
Weihao Liang
Zexuan Wu
Dexi Wu
Huiling Huang
Yuanyuan Zhou
Yugang Dong
Chen Liu
Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT
ESC Heart Failure
Heart failure with preserved ejection fraction
Pulmonary hospitalization
Risk factors
Prognosis
title Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT
title_full Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT
title_fullStr Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT
title_full_unstemmed Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT
title_short Clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction: from the TOPCAT
title_sort clinical implication of pulmonary hospitalization in heart failure with preserved ejection fraction from the topcat
topic Heart failure with preserved ejection fraction
Pulmonary hospitalization
Risk factors
Prognosis
url https://doi.org/10.1002/ehf2.12966
work_keys_str_mv AT bindong clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT xinhe clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT ruicongxue clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT yilichen clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT jingjingzhao clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT wengenzhu clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT weihaoliang clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT zexuanwu clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT dexiwu clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT huilinghuang clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT yuanyuanzhou clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT yugangdong clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat
AT chenliu clinicalimplicationofpulmonaryhospitalizationinheartfailurewithpreservedejectionfractionfromthetopcat